The Division of Nuclear Medicine is committed to excellence in the area of clinical service. Nuclear medicine techniques are applied for the diagnosis, management, therapy and prevention of many serious diseases. Areas of interest include oncology, cardiology, and neurology, among others.
The Division offers scintigraphic imaging of the brain, bones, thyroid, heart, lungs, and kidneys, as well as whole body imaging. In addition to these routine diagnostic procedures, special emphasis is placed on new radiopharmaceuticals, on single photon emission computed tomography (SPECT), and on positron emission tomography (PET), particularly as they apply to brain, cardiac and oncology studies. Our seven SPECT cameras and PET/CT system are fully interfaced with computers for acquisition and processing of imaging data. Quantitative aspects of SPECT and PET are also being developed. Our clinicians and scientists are actively involved in peptide imaging, immunoscintigraphy with monoclonal antibodies, gallium-67 planar and SPECT studies for the staging and follow-up of lymphoma, MIBI and thallium-201 tumor imaging, and radionuclide lymphoscintigraphy for both malignant processes and primary and secondary lymphedema.
The Division of Nuclear Medicine offers a wide range of procedures, applicable to a variety of systems and pathologies. Your physician may order a nuclear medicine study to aid in monitoring or diagnosing a problem affecting your:
- Cardiovascular system, such as coronary artery disease
- Central nervous system, such as Alzheimer’s disease
- Endocrine system, such as hyperthyroidism (Grave’s disease)
- Gastrointestinal system, such as acute gastrointestinal bleeding
- Genitourinary system, such as urinary tract obstruction
- Musculoskeletal system, such as occult bone trauma (often associated with sports injuries)
- Pulmonary system, such as pulmonary emboli
The Division of Nuclear Medicine also collaborates with other medical specialties to provide treatment and management of different diseases. Therapies offered in conjunction with the Division of Nuclear Medicine include:
- Radioiodine therapy for hyperthyroidism and thyroid cancer
- Radioimmunotherapy for lymphoma
- Therapy for bone pain
Marcelo Di Carli, MD
Chief
Victor H Gerbaudo, PhD
Director
Send Feedback to: 
